drugset / Trial / NCT01200524

A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..

NCT01200524 ↗

Phase 2 Completed 133 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgia.

Timeline

Start
2010-10
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD2423 Unknown 20 mg —
Subject AZD2423 Unknown 50 mg —

Indications